Physical Form
ChemicalBook > CAS DataBase List > Delafloxacin meglumine

Delafloxacin meglumine

Physical Form
Product Name
Delafloxacin meglumine
CAS No.
352458-37-8
Chemical Name
Delafloxacin meglumine
Synonyms
Delafloxcain meglumine;ABT 492 meglumine (Delafloxacin meglumine);100850;ABT492 MegluMine;ABT 492 MegluMine;ABT-492 MegluMine;RX-3341 meglumine;ABT-491 MegluMine;WQ-3034 meglumine);Delafloxacin Mcglumine
CBNumber
CB92666618
Molecular Formula
C25H29ClF3N5O9
Formula Weight
635.98
MOL File
352458-37-8.mol
More
Less

Delafloxacin meglumine Property

storage temp. 
under inert gas (nitrogen or Argon) at 2–8 °C
solubility 
Soluble in DMSO
form 
Powder
color 
Off-white to yellow
InChIKey
AHJGUEMIZPMAMR-KUAVVOKVNA-N
SMILES
[C@@H](O)([C@@H](O)CNC)[C@H](O)[C@H](O)CO.ClC1C(N2CC(O)C2)=C(F)C=C2C(=O)C(C(=O)O)=CN(C3N=C(N)C(F)=CC=3F)C=12 |&1:0,2,7,9,r|
More
Less

Hazard and Precautionary Statements (GHS)

More
Less

N-Bromosuccinimide Price

Cayman Chemical
Product number
27935
Product name
Delafloxacin (meglumine)
Packaging
10mg
Price
$62
Updated
2024/03/01
Cayman Chemical
Product number
27935
Product name
Delafloxacin (meglumine)
Packaging
250mg
Price
$1115
Updated
2024/03/01
Cayman Chemical
Product number
27935
Product name
Delafloxacin (meglumine)
Packaging
50mg
Price
$270
Updated
2024/03/01
Cayman Chemical
Product number
27935
Product name
Delafloxacin (meglumine)
Packaging
100mg
Price
$507
Updated
2024/03/01
ApexBio Technology
Product number
A3357
Product name
Delafloxacinmeglumine
Packaging
100mg
Price
$551
Updated
2021/12/16
More
Less

Delafloxacin meglumine Chemical Properties,Usage,Production

Physical Form

Solid

Description

Delafloxacin meglumine (Baxdela, WQ-3034, ABT-492, RX-3341; Melinta Therapeutics) was approved by the U.S. Food and Drug Administration (FDA) in June 2017 for the treatment of acute bacterial skin and skin structure infections on the basis of data from two phase III trials.

Uses

Delafloxacin is a broad-spectrum anionic fluoroquinolone and its distinct chemical structure increases its potency in acidic environments. It is known to inhibit DNA replication and repair by targeting DNA gyrase and topoisomerase IV. Delafloxacin is administered via both oral and parenteral routes. It has potent activity against methicillin-resistant Staphylococcus aureus and Streptococci, and is also effective against Enterobacteriaceae and Pseudomonas aeruginosa.

Indications

Delafloxacin meglumine (Baxdelae Melinta) is a fluoroquinolone antibacterial agent with properties that are most similar to other members of this class, such as levofloxacin, moxifloxacin, and ciprofloxacin. It is supplied in formulations for oral and intravenous administration. It is indicated for the treatment of adults with ABSSSIs caused by susceptible isolates of the gram-positive bacteria Staphylococcus aureus (including methicillin-resistant [MRSA] and methicillin-susceptible isolates), Staphylococcus haemolyticus, Staphylococcus lugdunensis, Streptococcus agalactiae, Streptococcus anginosus group (including S. anginosus, S. intermedius, and S. constellatus), Streptococcus pyogenes, and Enterococcus faecalis, and the gram-negative bacteria Escherichia coli, Enterobacter cloacae, Klebsiella pneumoniae, and Pseudomonas aeruginosa. It is the first fluoroquinolone to be demonstrated to be effective in the treatment of infections caused by MRSA, and its spectrum of antibacterial action, which also includes problem pathogens such as Pseudomonas aeruginosa, is broader than that of other antimicrobial agents that are indicated for the treatment of ABSSSIs[1].

Biological Activity

Delafloxacin meglumine (ABT492 meglumine; RX-3341 meglumine; WQ-3034 meglumine is a broad spectrum fluoroquinolone antibiotic. Delafloxacin has a wide range of activity against drug-resistant Staphylococcus aureus, Streptococcus pneumoniae and Klebsiella pneumoniae.

in vivo

Delafloxacin (the total daily doses vary from 0.156 to 640 mg/kg/24 h, subcutaneous injection) is highly effective against S. aureus. Against all four strains are observed a decrease of 1.5 to 2.2 log10 CFU in organism burden from untreated controls at even the lowest dose studied, and for two strains (MW2 and R2527) there is net bactericidal activity at the lowest dose. At the maximal doses studied, there is a >4-log10 kill from initial burden for all S. aureus strains[1].
Delafloxacin (2.5, 10, 40, and 160 mg/kg; subcutaneous injection, 24 h) has moderate terminal elimination half-life (t1/2=0.68 h, 0.79 h, 0.69 h and 1.0 h for 2.5 mg/kg, 10 mg/kg, 40 mg/kg, and 160 mg/kg, respectively)[1].

Animal Model:Mice with a neutropenic murine lung infection model (four S. aureus, four S. pneumoniae, and four K. pneumoniae strains)[1]
Dosage:The total daily doses vary from 0.156 to 640 mg/kg/24 h
Administration:0.03 to 160 mg/kg are administered every 6 h (q6h) to infected mice by subcutaneous injection
Result:Inhibited S. aureus strains ATCC 29213, ATCC 33591, MW2, R2527 with MICs of 0.008, 0.008, 0.004, and 0.004 mg/L, respectively.
Inhibited S. pneumoniae strains ATCC 10813, ATCC 49619, 145, and 1329 with MICs of 0.03, 0.125, 0.016, and 0.016 mg/L, respectively.
Inhibited K. pneumonia strains ATCC 43816, 4105, 4110, and 81-1260A with MICs of 0.06, 1, 0.5, and 0.06 mg/L, respectively.
Animal Model:Neutropenic mice[1]
Dosage:2.5, 10, 40, and 160 mg/kg; 0.2 mL
Administration:Subcutaneous injection; 24 h
Result:The maximum drug concentrations (Cmax) concentrations ranged from 2 to 71 mg/L. AUC0-∞ values ranged from 2.8 to 152 mg?h/L and were linear across the 2.5- to 160-mg dosing range. The elimination half-life (t1/2) ranged from 0.7 to 1 h.

IC 50

Quinolone

References

[1] Daniel A. Hussar, Molly A. Walter. “Delafloxacin meglumine, Meropenem trihydrate/vaborbactam, Secnidazole, and Benznidazole.” ACS Applied Bio Materials 58 2 (2018): Pages 223-227.

Delafloxacin meglumine Preparation Products And Raw materials

Raw materials

Preparation Products

More
Less

Delafloxacin meglumine Suppliers

Beijing HwrkChemical Technology Co., Ltd
Tel
18515581800 18501085097
Fax
010-89508210
Email
sales.bj@hwrkchemical.com
Country
China
ProdList
9400
Advantage
55
Nanjing Sunlida Biological Technology Co., Ltd.
Tel
025-57798810
Fax
025-57019371
Email
sales@sunlidabio.com
Country
China
ProdList
3239
Advantage
55
AdooQ BioScience, LLC
Tel
+1 (866) 930-6790
Fax
+1 (866) 333-9607
Email
info@adooq.com
Country
United States
ProdList
2782
Advantage
58
TargetMol Chemicals Inc.
Tel
021-021-33632979 15002134094
Fax
021-33632979
Email
marketing@targetmol.com
Country
China
ProdList
7783
Advantage
58
CEG Chemical Science&Technology Co., Ltd.
Tel
Mobile:13665161512
Fax
+86-510-68873513
Country
China
ProdList
1785
Advantage
58
ShangHai Caerulum Pharma Discovery Co., Ltd.
Tel
18149758185
Email
sales-cpd@caerulumpharma.com
Country
China
ProdList
3506
Advantage
58
Hangzhou J&H Chemical Co., Ltd.
Tel
0571-87396432
Fax
0571-87396431
Email
sales@jhechem.com
Country
China
ProdList
14912
Advantage
59
Jiangsu Aikon Biopharmaceutical R&D co.,Ltd.
Tel
025-66028182 18626450290
Email
yftan@aikonchem.com
Country
China
ProdList
16679
Advantage
50
AdooQ Bioscience CHINA
Tel
025-58849295 18951903616;
Fax
025-68650336
Email
info@adooq.cn
Country
China
ProdList
2990
Advantage
60
LETOPHARM LIMITED
Tel
+86-21-5821 5861
Fax
+86-21-5106 2861
Email
sales@letopharm.com
Country
China
ProdList
2384
Advantage
58
More
Less

View Lastest Price from Delafloxacin meglumine manufacturers

Shaanxi Dideu New Materials Co. Ltd
Product
Delafloxacin meglumine 352458-37-8
Price
US $0.00/kg
Min. Order
1kg
Purity
98%
Supply Ability
1000kg
Release date
2025-09-29
BEIJING SJAR TECHNOLOGY DEVELOPMENT CO., LTD.
Product
Delafloxacin Meglumine 352458-37-8
Price
US $0.00/g
Min. Order
1g
Purity
More Than 99%
Supply Ability
100kg/Month
Release date
2024-08-05
Jinan Ande Pharmaceutical Co.,Ltd.
Product
Delafloxcain meglumine 352458-37-8
Price
US $0.00/KG
Min. Order
1KG
Purity
99%
Supply Ability
100
Release date
2021-12-18

352458-37-8, Delafloxacin meglumineRelated Search:


  • 100850
  • ABT 492 meglumine (Delafloxacin meglumine)
  • Delafloxacin meglumine (ABT492 meglumine
  • (2R,3R,4R,5S)-2,3,4,5-tetrahydroxy-6-(MethylaMino)hexyl 1-(6-aMino-3,5-difluoropyridin-2-yl)-8-chloro-6-fluoro-7-(3-hydroxyazetidin-1-yl)-4-oxo-1,4-dihydroquinoline-3-carboxylate
  • ABT 492 MegluMine
  • ABT492 MegluMine
  • ABT-492 MegluMine
  • Delafloxacin (MegluMine)
  • ABT-492MegluMine/ABT492MegluMine
  • (2R,3R,4R,5S)-6-(MethylaMino)hexane-1,2,3,4,5-pentaol 1-(6-aMino-3,5-difluoropyridin-2-yl)-8-chloro-6-fluoro-7-(3-hydroxyazetidin-1-yl)-4-oxo-1,4-dihydroquinoline-3-carboxylate
  • (2R,3R,4R,5S)-2,3,4,5-Tetrahydroxy-6-(methylamino)hexyl 1-(6-amino-3,5-difluoropyridin-2-yl)-8
  • Delafloxacin meglumine (Synonyms: ABT492 meglumine
  • RX-3341 meglumine
  • WQ-3034 meglumine)
  • D-Glucitol, 1-deoxy-1-(methylamino)-, 1-(6-amino-3,5-difluoro-2-pyridinyl)-8-chloro-6-fluoro-1,4-dihydro-7-(3-hydroxy-1-azetidinyl)-4-oxo-3-quinolinecarboxylate (1:1)
  • ABT492 MEGLUMINE; ABT-492 MEGLUMINE; DELAFLOXACIN MEGLUMINE
  • Delafloxcain meglumine
  • ABT-491 MegluMine
  • (2R,3R,4R,5S)-2,3,4,5-Tetrahydroxy-6-(methylamino)hexyl 1-(6-amino-3,5-difluoropyridin-2-yl)-8-chloro-6-fluoro-7-(3-hydroxyazetidin-1-yl)-4-oxo-1,4-dihydroquin
  • Delafloxacin Mcglumine
  • elafloxcain Delafloxcain meglumine
  • ethyl(3R)-piperidine-9-carboxylate
  • Delafloxacin meglumine Impurity
  • Delafloxacin meglumine, 10 mM in DMSO
  • 352458-37-8
  • C18H12ClF3N4O4C7H17NO5
  • C25H29ClF3N5O9
  • C25H27ClF3N5O8
  • API